Notice of Annual General Meeting of Genovis AB (publ)

Shareholders of GENOVIS AB (publ) are hereby summoned to an extra General Meeting (“the Meeting”) to be held on Tuesday, September 8, 2009, at 5:00 p.m. at Scheelevägen 22, Lund, Sweden.

Participation To be entitled to participate in the business of the Meeting, shareholders must be recorded in the register of shareholders maintained by Euroclear Sweden AB (former VPC AB, the Swedish Securities Register Center) on September 2, 2009, and must notify Genovis of their intention to attend the Meeting no later than September 2, 2009. Nominee-registered shares Shareholders whose shares are registered in the name of a nominee through the trust department of a bank or similar institution must, in order to be entitled to participate in the Meeting, request that their shares are temporarily re-registered in their own names in the register of shareholders maintained by Euroclear Sweden AB. Such registration must be effected, September 2, 2009. Shareholders are requested to inform their nominees well in advance of this date. Notification • mail to GENOVIS AB (publ), Box 270, 220 07 Lund • telephone +46 (0)46-10 12 38 • fax +46 (0)46-12 80 20 • e-mail: info@genovis.com When registering, shareholders should state their: • name/company name • personal identification or corporate identity number • address, telephone number • name and personal identification number of any representatives • name of the attendance of any assistants Agenda 1. Opening of the meeting. 2. Election of chairman for the meeting. 3. Preparation and approval of voting list. 4. Approval of the agenda. 5. Election of two persons to attest to the accuracy of the minutes. 6. Decision on whether proper notice of the Meeting has been made. 7. The Board of Director's proposal for resolutions regarding a new share issue. The board proposes that the extraordinary General Meeting decides on a new share issue with preferential rights for existing shareholders, at which two existing shares give right to the subscription of one new share at issue price of SEK 1 per share. The decision means that the share capital can be increased with altogether SEK 2 813 293,2 through the issuing of 7 033 233 new shares. Following the completed share issue the share capital will amount to, at the maximum, SEK 8 439 879,6, and the number of shares to 21 099 699. The company receives approx. SEK 7 million before costs for the share issue. The share issue results in a dilution effect of 33%. 8. Conclusion of the Meeting Documents The Board of Directors' complete proposals will be made available at Genovis and on Genovis website, www.genovis.com, no later than September 25, 2009 and will be sent to shareholders that request the Company to do so. Lund August, 2009 Board of Directors